SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-24-084642
Filing Date
2024-08-01
Accepted
2024-08-01 08:00:08
Documents
1
Group Members
ADAR1 CAPITAL MANAGEMENT GP, LLCDANIEL SCHNEEBERGER

Document Format Files

Seq Description Document Type Size
1 SC 13G tm2420593d1_sc13g.htm SC 13G 83468
  Complete submission text file 0001104659-24-084642.txt   85249
Mailing Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110
Business Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Subject) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88917 | Film No.: 241164413
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3503 WILD CHERRY DRIVE BUILDING 9 AUSTIN TX 78738
Business Address 3503 WILD CHERRY DRIVE BUILDING 9 AUSTIN TX 78738 512-254-3790
ADAR1 Capital Management, LLC (Filed by) CIK: 0001940272 (see all company filings)

IRS No.: 000000000 | State of Incorp.: TX | Fiscal Year End: 1231
Type: SC 13G